#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma recurrent Arterial tortuosity syndrome Small cell lung cancer recurrent Hyperphagia Congenital leptin deficiency Partial lipodystrophy Retinitis pigmentosa Cardiomyopathy Microscopic polyangiitis Waldenstrom's macroglobulinaemia Chronic inflammatory demyelinating polyradiculoneuropathy Ehlers-Danlos syndrome Congenital disorder of glycosylation Heritable pulmonary arterial hypertension Congenital myopathy More trials…

    Learn about Rare Diseases

    Proteus syndrome – Life with Disease Alport’s syndrome – Treatment Metachromatic leukodystrophy – Trials in Disease Rhabdomyosarcoma recurrent – Life with Disease Wolfram syndrome Ewing’s sarcoma recurrent Noonan syndrome – Basic Information Pulmonary fibrosis – Basic Information Langerhans cell sarcoma – Treatment Hereditary optic atrophy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amitriptyline Hydrochloride Nifedipine KETOROLAC TROMETAMOL Clavulanic Acid A3907 Blu-222 INSULIN DEGLUDEC Pevonedistat Rp1 Varegacestat SULBACTAM SODIUM SARACATINIB GS-4321 Palmidrol Dapansutrile LTI-03 Timbetasin Acetate O15-Water 1,3-BUTYLENE GLYCOL Ipilimumab More therapies…

    Learn about Your Condition

    Systemic infection Peptostreptococcus infection Dementia with Lewy bodies Respiratory distress Post procedural infection Progressive supranuclear palsy Renal cancer recurrent Ocular melanoma Stomatitis Gestational diabetes Endocarditis bacterial Lupus nephritis Ovarian cancer Naevoid melanoma Inclusion body myositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Safety of EDV2209 for Patients with Brain Bleeding (Subarachnoid Hemorrhage)

    Recruiting

    2 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • 1,4-Diamino-2,3-Dicyano-1,4-Bis(O-Aminophenylmercapto)Butadiene Hemiethanolate
    Denmark

  • Study on Rimegepant for Preventing Migraines in Children and Teens Aged 6 to 17

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Rimegepant
    France Italy Poland Spain

  • Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

    Recruiting

    2 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia France Hungary +3

  • Study on Pain Relief Using Serratus Plane Block with Ropivacaine, Lidocaine Hydrochloride, and Dexamethasone Sodium Phosphate for Intensive Care Patients Undergoing Pleural Drainage

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ropivacaine
    • Lidocaine Hydrochloride
    • Dexamethasone Sodium Phosphate
    France

  • Study on Stopping or Continuing Clopidogrel, Carbasalate Calcium, and Dipyridamole for Young Patients After Stroke Without a Known Cause

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • Carbasalate Calcium
    • Dipyridamole
    • Acetylsalicylic Acid
    The Netherlands

  • Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

    Recruiting

    3 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    The Netherlands
Previous Page
1 … 28 29 30 31 32 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!